Standard BioTools Inc. (LAB) dividend history
LABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3087% below fair value
$0.65+0.01 (+1.31%)
Close on Nov 12, 2026Market cap $255.73MP/E 3.0Yield –
Dividends
Standard BioTools has not reported a dividend
No dividend per share appears in Standard BioTools's annual filings since fiscal 2010.
See a number that looks wrong?